Stock listing
AVCN Stock Price, News, Filings & Events — Avicanna Inc
Selected listing: AVCN · NEO · CAD · CA
This page tracks Avicanna Inc's AVCN:NEO listing on NEO in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AVCN:NEO. AVCN:NEO is the stock-level entry point for investors researching Avicanna Inc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Avicanna Inc is a public company listed on the Canadian market under the ticker AVCN. With a market capitalization of approximately CAD 11.6 million, Avicanna focuses on the development and commercialization of cannabinoid-based products. The company is committed to advancing the cannabis industry through innovative research and product offerings.
- Ticker
- AVCN:NEO
- Asset type
- Stock
- Market cap
- $12.6M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NEO
- Currency
- CAD
Avicanna Inc AVCN:NEO stock context
This page tracks Avicanna Inc's AVCN:NEO listing on NEO in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AVCN:NEO. AVCN:NEO is the stock-level entry point for investors researching Avicanna Inc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Avicanna Inc is a public company listed on the Canadian market under the ticker AVCN. With a market capitalization of approximately CAD 11.6 million, Avicanna focuses on the development and commercialization of cannabinoid-based products. The company is committed to advancing the cannabis industry through innovative research and product offerings.
Latest news from Avicanna Inc
Avicanna Announces Closing of Strategic Non-Brokered Private Placement
August 19, 2026
Avicanna Reports Q2 2026 Financial Results
August 14, 2026
Avicanna Introduces QUIX™ Rapid-Onset Medical Cannabis Portfolio
July 16, 2026
Avicanna Announces Promotion of Nick Hilborn CPA CA to Chief Financial Officer
June 30, 2026
Splash Beverage Group Invests in Avicanna, a Leading Cannabinoid Biopharmaceutical Platform, Advancing Its Transformation Into Cannabinoi...
June 15, 2026
Avicanna Inc earnings calls
Research Avicanna Inc
Avicanna Inc investor report
Review AI stock analysis and investor report context for AVCN:NEO.
Avicanna Inc company profile
View the public company page for Avicanna Inc on 6ix.
Avicanna Inc news
Read company news and market updates connected to Avicanna Inc.
Avicanna Inc investor events
Find investor webinars, events, and replay context for Avicanna Inc.
Alternate listings
AVCN:TSX
CA · CAD
Alternate listing for Avicanna Inc; the primary context on this page is AVCN:NEO.
AVCNF:OTC
US · USD
Alternate listing for Avicanna Inc; the primary context on this page is AVCN:NEO.
A2PN04:LSX
DE · EUR
Alternate listing for Avicanna Inc; the primary context on this page is AVCN:NEO.
A2PN04:LS
DE · EUR
Alternate listing for Avicanna Inc; the primary context on this page is AVCN:NEO.
0NN:GETTEX
DE · EUR
Alternate listing for Avicanna Inc; the primary context on this page is AVCN:NEO.
0NN:FWB
DE · EUR
Alternate listing for Avicanna Inc; the primary context on this page is AVCN:NEO.
0NN:MUN
DE · EUR
Alternate listing for Avicanna Inc; the primary context on this page is AVCN:NEO.
0NN:SWB
DE · EUR
Alternate listing for Avicanna Inc; the primary context on this page is AVCN:NEO.